Suraj Kalia
Stock Analyst at Oppenheimer
(3.10)
# 1,209
Out of 5,139 analysts
88
Total ratings
47.3%
Success rate
12.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Outperform | $125 → $100 | $88.07 | +13.55% | 1 | Jan 16, 2026 | |
| INSP Inspire Medical Systems | Upgrades: Outperform | $175 | $92.23 | +89.74% | 3 | Dec 8, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $13.79 | +30.53% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $84.35 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $30.38 | +97.50% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $14.25 | +54.39% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $143.37 | +4.62% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $39.06 | +15.21% | 7 | Feb 13, 2025 | |
| IRTC iRhythm Holdings | Maintains: Outperform | $105 → $120 | $167.16 | -28.21% | 7 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $43.39 | -26.25% | 3 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $90 → $93 | $88.24 | +5.39% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $130 | $121.76 | +6.77% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $5.53 | +81.00% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $5.01 | +159.48% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $85.78 | +57.38% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $257.58 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $30.46 | -1.51% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $1.70 | +11,664.71% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $81.75 | +18.65% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $24.42 | +14.66% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $4.16 | +8.17% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.11 | +1,341.44% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $535.00 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $8.00 | +8,150.00% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.15 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $20.11 | +397.27% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $69.54 | - | 5 | Sep 12, 2018 |
Boston Scientific
Jan 16, 2026
Maintains: Outperform
Price Target: $125 → $100
Current: $88.07
Upside: +13.55%
Inspire Medical Systems
Dec 8, 2025
Upgrades: Outperform
Price Target: $175
Current: $92.23
Upside: +89.74%
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $13.79
Upside: +30.53%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $84.35
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $30.38
Upside: +97.50%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $14.25
Upside: +54.39%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $143.37
Upside: +4.62%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $39.06
Upside: +15.21%
iRhythm Holdings
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $167.16
Upside: -28.21%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $43.39
Upside: -26.25%
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $88.24
Upside: +5.39%
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $121.76
Upside: +6.77%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.53
Upside: +81.00%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $5.01
Upside: +159.48%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $85.78
Upside: +57.38%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $257.58
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $30.46
Upside: -1.51%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $1.70
Upside: +11,664.71%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $81.75
Upside: +18.65%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $24.42
Upside: +14.66%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $4.16
Upside: +8.17%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.11
Upside: +1,341.44%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $535.00
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $8.00
Upside: +8,150.00%
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.15
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $20.11
Upside: +397.27%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $69.54
Upside: -